Oncology Views & Analysis

Views & Analysis

Secondary-effects-of-COVID-19-on-the-pharma-healthcare-and-patients

Secondary effects of COVID-19 on pharma, healthcare and pati...

Reminders of the impact of the COVID-19 pandemic on our healthcare system, economy, and day-to-day lives are everywhere.

Views & Analysis

Coping with a life-changing diagnosis during COVID-19

As the UK went into COVID-induced lockdown, Matthew and Hayley Smith were receiving the news they had dreaded for four years – that Matthew’s brain tumour had come back.

Views & Analysis

‘More people will die from pancreatic cancer’: How COVID-19 ...

More people with pancreatic cancer will die from the disease if the COVID-19 crisis continues to demand the lion’s share of clinical time and resources.

Views & Analysis

Patient research is critical to brand success, particularly ...

We see it time and time again in the treatment of cancer – pharma companies focusing all their effort on oncologists.

Views & Analysis

Macrophage Pharma goes for gold with new funding round

Richard Staines spoke with Soren Bregenholt, the new CEO of Macrophage Pharma, about the company’s strategy encompassing both immune oncology and inflammatory diseases.

Views & Analysis

Helsinn’s Riccardo Braglia on the patient perspective in can...

Swiss cancer care company Helsinn has become unique in the industry by remaining a family business over three generations.

Secondary effects of COVID-19 on pharma, healthcare and pati...

Coping with a life-changing diagnosis during COVID-19

‘More people will die from pancreatic cancer’: How COVID-19 ...

Patient research is critical to brand success, particularly ...

Macrophage Pharma goes for gold with new funding round

Helsinn’s Riccardo Braglia on the patient perspective in can...

On AI and computational support of biochemistry, with Alan R...

The AI imperative: Establishing the standard for modern clin...

Views & Analysis

Editor's Picks